As the internet information retrieval ecosystem continues to evolve, the path for academic information delivery in specialized prescription drugs is undergoing a fundamental change. The old model, which relied on academic journals, offline conferences, and traditional search engines, is becoming less efficient. GEO, or Generative Engine Optimization, built on large-model AI Q&A ecosystems, is becoming a new track for prescription drug brands to reach healthcare professionals (HCPs). As a service provider deeply focused on digital intelligence marketing in life sciences, MeDomino combines years of HCP insight and medical compliance experience to clarify the underlying logic differences between SEO and GEO. Based on a mature GEO methodology, we implement practical projects for specialized prescription drugs, helping brands enter HCP professional discussion scenarios accurately and communicate precise academic value.
1. SEO and GEO: Different Marketing Logic in Two Information Ecosystems
1. Traditional SEO: passive reach in the keyword search era
Traditional SEO is rooted in general search engines. For specialized prescription drugs under strict compliance regulation, marketing can only focus on academic keyword planning and professional website optimization. HCPs need to actively enter keywords, then screen large numbers of academic links to find guidelines, evidence, and medication information. Brands can only wait passively to be discovered by professionals. Information delivery is inefficient and not precise enough.
This model served as an important supplement to prescription drug academic promotion for a long time. But as generative AI becomes widely adopted, HCP habits for obtaining professional information are changing dramatically, and the original academic information reach logic is increasingly limited.
2. GEO: new rules for active academic delivery in the AI-generated Q&A era
GEO means Generative Engine Optimization. It adapts to the new information environment of professional Q&A powered by large AI models. Many clinicians, pharmacists, and other HCPs now use large-model tools and ask AI directly to search and integrate academic materials, such as "latest guideline recommendations for first-line treatment of a certain disease." AI then generates structured professional answers directly.
The core of GEO is to optimize the exposure probability and presentation accuracy of brand academic information in AI-generated answers, and to correct AI misunderstandings about drug indications and evidence levels. It upgrades the goal from "letting HCPs find literature links" to "letting AI accurately present the brand's professional value." It is a new-generation content optimization system that fits compliance requirements for prescription drug academic promotion.
2. MeDomino's GEO Implementation Thinking: Anchored in Real HCP Clinical Decision Scenarios
MeDomino's prescription drug GEO service logic is grounded in the industry characteristics of prescription drugs and the decision-making patterns of HCPs. Instead of using generic optimization templates, it builds an optimization system anchored in professional needs and AI rules:
1. Anchor content direction in high-frequency HCP professional questions
We go deep into specialized disease diagnosis and treatment scenarios, understand core target groups such as clinicians and pharmacists, and focus on the professional needs HCPs care about most, including monitoring guidelines, clinical evidence, treatment paths, and adverse reactions. This fits their professional habit of relying heavily on authoritative evidence in decision-making and helps us map the real professional questions they ask AI in daily work.
2. Refine academic materials according to large-model professional answer generation rules
We build brand academic content around real clinical questions from HCPs and fully adapt it to AI professional content generation logic. From drug indications, key clinical studies, guideline consensus, and contraindications, we improve brand-owned academic assets to ensure professionalism and compliance, giving AI enough credible evidence when it integrates professional answers.
3. Iterate through long-term data tracking
We use a periodic long-term operating model to monitor brand mention data and information accuracy across AI professional Q&A scenarios in stages. Based on evidence presentation deviations in AI answers, we continuously optimize content and gradually improve the brand's priority and credibility in AI recommendation systems for HCP professional scenarios.
3. MeDomino Implementation Case: Practical GEO for a Specialized Prescription Drug Category
Prescription drugs are one of the most compliance-intensive segments in life sciences. HCP decisions are fully based on monitoring guidelines, clinical evidence, and medication pathways, while questions are highly focused on professional academic content. This category has become a benchmark professional scenario for MeDomino's GEO solution.
GEO pain points in this category
Professional scenarios have extremely high compliance requirements. Ordinary content cannot meet regulatory standards for pharmaceutical academic promotion, and compliant AI-citable materials are difficult to produce at scale.
Academic information in the industry is scattered. Most brands struggle to enter core HCP professional discussions, and brand mentions in AI-generated professional answers are often low.
Evidence statements from different sources vary in quality. Combined with large-model hallucinations, this makes related AI outputs unstable and prevents accurate communication of the brand's core academic value.
MeDomino's GEO implementation actions
Step 1: User need analysis - restore real HCP clinical decision scenarios
Based on years of MeDomino HCP360 insight experience, we use user probes and demand modeling to accurately identify the core target HCP groups for specialized prescription drugs, such as clinicians in relevant departments, and deeply analyze their academic needs and decision journeys at different diagnosis and treatment stages.
- Systematically map full-dimensional professional consultation scenarios for the specialized disease, focusing on high-frequency question directions such as clinical guidelines, evidence-based data, indications, medication pathways, and adverse reactions.
- Simulate HCP personas with different titles and clinical experience to generate real professional questions and build a complete academic question map for the specialty.
- Combine brand academic promotion goals to identify high-value clinical decision questions as the core optimization targets.
Step 2: AI answer monitoring - analyze brand professional AI visibility across platforms
For mainstream large models such as Doubao, Tongyi Qianwen, Yuanbao, and DeepSeek, we parse and extract insights from professional AI answers related to specialized diseases one by one:
- Quantitatively monitor core professional metrics such as brand mention rate, first mention rate, and core focus accuracy across platforms.
- Analyze how well AI answers match brand clinical evidence and guideline recommendations, precisely locating missing information and academic expression deviations.
- Study large-model source citation preferences and identify high-weight channels to guide subsequent academic content placement.
Step 3: Content generation and placement - build compliant and credible brand academic assets
Using the MeDomino Content Hub AIGC content generation system, we generate highly compliant brand academic content targeted to issues found in AI answers:
- Based on MeDomino's life sciences enterprise knowledge base, and combined with the client's package insert, clinical guidelines, evidence-based studies, and other authoritative materials, we systematically build assets covering product indications, key study data, guideline consensus interpretation, and professional FAQ.
- All content undergoes dual medical and compliance review by independent AI agents and strictly follows NMPA and pharmaceutical academic promotion regulations.
- The refined compliant academic content is placed precisely on authoritative medical media and professional academic platforms frequently cited by large models, turning it into trusted sources AI can adopt and helping brand information naturally enter high-quality AI answers in HCP scenarios.
Step 4: Core data presentation - build a transparent and traceable professional effectiveness system
Through the GEO monitoring dashboard, we present core professional brand data in real time and form a continuous closed loop of monitoring, analysis, optimization, and re-monitoring:
- Dynamically track key indicators such as brand mention rate, core focus accuracy, and positive sentiment ratio.
- Regularly generate reports on AI insight competitive landscape, academic risk points, and optimization strategies.
- Continuously adjust academic content direction and placement strategy based on data feedback, steadily improving the brand's accuracy and credibility in AI recommendation systems for HCP professional scenarios.
4. Conclusion
The trend of AI reshaping professional information acquisition is irreversible. From SEO to GEO, neither replaces offline visits, academic conferences, or other promotion models, but GEO is an inevitable upgrade for prescription drug brands adapting to the evolution of large-model AI ecosystems. MeDomino continues to stand on the bottom line of pharmaceutical compliance and life sciences professionalism, refining a GEO implementation system for prescription drugs. Based on real clinical scenarios and evidence-based data, we help more prescription drug brands build professional and credible academic influence in the new generative AI environment.
